Compare Crowdstrike Holdings Inc (CRWD) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crowdstrike Holdings Inc vs Koninklijke Philips NV — how do they compare? Crowdstrike Holdings Inc trades at $207.49 (market cap $214.58B), while Koninklijke Philips NV trades at $27.09 (market cap $25.47B). The key difference: Crowdstrike Holdings Inc is far larger — about 8.4× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays a 3.89% dividend while Crowdstrike Holdings Inc pays none. Which is the better fit depends on your goals.
| CRWD | PHG | |
|---|---|---|
Market Cap | $214.58B | $25.47B |
Sector | Technology | Health |
52-Week High | $210.73 | $32.91 |
52-Week Low | $87.56 | $24.11 |
Enterprise Value | $210.85B | $31.74B |
Dividend Yield | — | 3.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CrowdStrike (CRWD) trades at $187.91, up 0.39% on the day, with a bullish technical signal and strong support near $185. The stock has delivered three consecutive quarterly EPS beats, with Q2 2026 expected at $0.29. Revenue growth remains robust, rising from $1.5B in 2022 to $4.0B in 2025, though net margins are slightly negative. A recent 4-for-1 stock split on July 2, 2026, has increased accessibility amid heightened investor interest in AI-driven cybersecurity.
Outlook is supported by solid cash flow growth and dominant market positioning, but premium valuations (P/E 765, P/S 37) pose risks if growth decelerates. Analyst consensus is strongly bullish with a $184.39 price target, though competitive pressures and execution challenges remain key watchpoints for sustained upside.
PHG trades at $27.34, down 0.22% on the day, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operating cash flow of $1.17B. Recent FDA clearances for AI-powered medical devices and strategic healthcare partnerships demonstrate innovation momentum.
The stock presents a mixed outlook with 41% analyst buy ratings but bearish technical indicators. Key opportunities include AI healthcare adoption and margin expansion, while risks involve competitive pressures and debt levels. Valuation appears reasonable with P/E of 24.01 and P/S of 1.31, but requires monitoring of execution against growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crowdstrike Holdings Inc
CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
